SAMFINE CREATION HOLDINGS GROUP LIMITED Announces First Half 2024 Unaudited Financial Results
HONG KONG, Dec. 20, 2024 (GLOBE NEWSWIRE) — SAMFINE CREATION HOLDINGS GROUP LIMITED (Nasdaq: SFHG) (the “Company” or “Samfine”), a […]
Onfolio Holdings Inc. Announces Quarterly Preferred Stock Cash Dividend of $0.75 Per Share
WILMINGTON, Del., Dec. 20, 2024 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) (the “Company” or “Onfolio”), a […]
Bridgeline to Report Financial Results for the Fourth Quarter of Fiscal 2024
WOBURN, Mass., Dec. 20, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, […]
SigmaTron International, Inc. Reports Financial Results For the Second Quarter of Fiscal 2025
ELK GROVE VILLAGE, Ill., Dec. 20, 2024 (GLOBE NEWSWIRE) — SigmaTron International, Inc. (NASDAQ: SGMA), an electronic manufacturing services company […]
ARMLOGI HOLDING CORP. CLOSES ON $5 MILLION SECOND TRANCHE OF PRE-PAID ADVANCE UNDER A STANDBY EQUITY PURCHASE AGREEMENT
WALNUT, CA, Dec. 20, 2024 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing […]
Giftify, Inc. Announces $5.0 Million Registered Direct Offering
SCHAUMBURG, IL, Dec. 20, 2024 (GLOBE NEWSWIRE) — Giftify, Inc. (NASDAQ: GIFT) (the “Company”), the owner and operator of leading […]
Renovaro Regains Compliance with NASDAQ Listing Requirement
LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered […]
LiveOne (NASDAQ: LVO) Regains Compliance with Nasdaq Listing Requirements
LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, announced […]
NBT Bancorp Inc. Receives Regulatory Approval, Evans Bancorp, Inc. Shareholders Approve Merger
NORWICH, N.Y. and WILLIAMSVILLE, N.Y., Dec. 20, 2024 (GLOBE NEWSWIRE) — NBT Bancorp Inc. (“NBT”) (NASDAQ: NBTB) announced that it […]
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old
BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the […]
